基于“以筋调骨”理念探讨穴位埋线对膝骨关节炎的疗效

doi:10.3760/cma.j.cn441417-20241129-11026

摘要/Abstract

摘要：

目的　基于“以筋调骨”理念探讨穴位埋线在膝骨关节炎中的效果。方法　本研究为随机对照试验，选取2021年3月至2024年3月西安交通大学第一附属医院榆林医院康复医学科收治的150例膝骨关节炎患者为研究对象，通过随机数字表法分为对照组和观察组各75例。对照组男42例，女33例；年龄（63.35±8.42）岁；病程（20.36±5.17）个月；病变部位：左膝26例，右膝32例，双膝17例。观察组男40例，女35例；年龄（62.08±9.13）岁；病程（21.52±4.86）个月；病变部位：左膝28例，右膝31例，双膝16例。对照组采用常规西医治疗：口服塞来昔布胶囊，每次0.2 g，每天1次，连续服用4周；观察组在对照组基础上联合穴位埋线治疗：于治疗第1天、第7天、第14天、第21天、第28天各埋线一次，共5次。对比治疗前后两组患者疼痛、膝关节功能、膝骨关节炎严重程度以及血清炎症因子、疼痛介质水平，并比较临床疗效和安全性。采用t检验和χ2检验进行统计学分析。结果　治疗后，两组视觉模拟评分法（Visual Analogue Scale，VAS）评分、西安大略和麦克马斯特大学骨关节炎指数（Western Ontario and McMaster Universities Osteoarthritis Index，WOMAC）均降低（均P<0.05），且观察组低于对照组［（1.48±0.19）分比（2.97±0.41）分、（20.52±4.03）分比（30.65±5.29）分］（t=28.555、13.192，均P<0.05）；两组Lysholm膝关节评分均升高（P<0.05），且观察组高于对照组［（79.95±8.13）分比（64.83±8.26）分］（t=11.298，P<0.05）；两组血清白介素-1（interleukin-1，IL-1）、IL-6、肿瘤坏死因子-α（tumor necrosis factor-α，TNF-α）、基质金属蛋白酶3（matrix metalloproteinase-3，MMP-3）、P物质（substance P，SP）、多巴胺（dopamine，DA）、前列腺素E2（prostaglandin E2，PGE2）水平均降低（均P<0.05），且观察组低于对照组［（101.59±10.17）ng/L比（132.88±11.64）ng/L、（113.68±16.71）ng/L比（147.95±18.56）ng/L、（4.36±0.92）ng/L比（6.41±1.55）ng/L、（90.36±14.76）μg/L比（125.42±18.61）μg/L、（139.53±20.32）μg/L比（176.41±25.84）μg/L、（7.85±1.16）μg/L比（11.92±1.59）μg/L、（121.86±21.95）μg/L比（179.63±28.77）μg/L］（t=17.531、11.884、9.850、12.783、9.716、17.909、13.825，均P<0.05）。观察组临床总有效率高于对照组［96.00%（72/75）比84.00%（63/75）］（χ2=6.000，P=0.014）。两组均未出现严重不良反应。结论　基于“以筋调骨”理念对膝骨关节炎患者实施穴位埋线治疗，可有效减轻患者疼痛与病情严重程度，改善膝关节功能，降低炎症因子和疼痛介质水平，临床效果与安全性佳。

关键词: 膝骨关节炎, 以筋调骨, 穴位埋线, 疼痛, 膝关节功能

Abstract:

Objective　To explore the effect of catgut implantation at acupoint in the treatment of knee osteoarthritis based on the concept of "regulating bone with tendons". Methods　This study was a randomized controlled trial. A total of 150 patients with knee osteoarthritis admitted to the Department of Rehabilitation Medicine of Xi'an Jiaotong University First Affiliated Hospital Yulin Hospital from March 2021 to March 2024 were selected as the research subjects and were divided into a control group and an observation group, with 75 cases in each group, by the random number table method. In the control group, there were 42 males and 33 females, aged (63.35±8.42) years, the disease duration was (20.36±5.17) months, and there were 26 cases on the left knee, 32 cases on the right knee, and 17 cases on both knees. In the observation group, there were 40 males and 35 females, aged (62.08±9.13) years, the disease course was (21.52±4.86) months, and there were 28 cases on the left knee, 31 cases on the right knee, and 16 cases on both knees. The control group received conventional western medicine treatment: oral celecoxib capsules, 0.2 g each time, once a day, for 4 consecutive weeks; the observation group received catgut implantation at acupoint on the basis of the control group: catgut implantation was done once on the 1st, 7th, 14th, 21st, and 28th days of the treatment, for a total of 5 times. The pain, knee joint function, severity of knee osteoarthritis, and levels of serum inflammatory factors and pain mediators were compared between the two groups before and after treatment, as well as the clinical efficacy and safety. Statistical analysis was performed using t-test and χ² test. Results　After treatment, the Visual Analogue Scale (VAS) score and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were decreased in both groups (all P<0.05), and those in the observation group were lower than those in the control group [(1.48±0.19) points vs. (2.97±0.41) points, (20.52±4.03) points vs. (30.65±5.29) points] (t=28.555 and 13.192; both P<0.05). After treatment, the Lysholm knee joint score was increased in both groups (both P<0.05), and the score of the observation group was higher than that of the control group [(79.95±8.13) points vs. (64.83±8.26) points] (t=11.298, P<0.05). After treatment, the levels of serum interleukin-1 (IL-1), IL-6, tumor necrosis factor-α (TNF-α), matrix metalloproteinase-3 (MMP-3), substance P (SP), dopamine (DA), and prostaglandin E₂ (PGE₂) were all decreased in both groups (all P<0.05), and those in the observation group were lower than those in the control group [(101.59±10.17) ng/L vs. (132.88±11.64) ng/L, (113.68±16.71) ng/L vs. (147.95±18.56) ng/L, (4.36±0.92) ng/L vs. (6.41±1.55) ng/L, (90.36±14.76) μg/L vs. (125.42±18.61) μg/L, (139.53±20.32) μg/L vs. (176.41±25.84) μg/L, (7.85±1.16) μg/L vs. (11.92±1.59) μg/L, (121.86±21.95) μg/L vs. (179.63±28.77) μg/L (t=17.531, 11.884, 9.850, 12.783, 9.716, 17.909, and 13.825, all P<0.05). The total clinical effective rate of the observation group was higher than that of the control group [96.00% (72/75) vs. 84.00% (63/75)] (χ²=6.000, P=0.014). Both groups did not experience any serious adverse reactions. Conclusion　Based on the concept of "regulating bone with tendons", catgut implantation at acupoint for patients with knee osteoarthritis can effectively reduce the pain and severity of the condition, improve the knee joint function, reduce the levels of inflammatory factors and pain mediators, and has good clinical efficacy and safety.

Key words: Knee osteoarthritis, , Regulating bone with tendons, , Catgut implantation at acupoint, , Pain, , Knee joint function

冯信马宁王飞. 基于“以筋调骨”理念探讨穴位埋线对膝骨关节炎的疗效 [J]. 国际医药卫生导报, 2025, 31(11): 1900-1905.

Feng Xin, Ma Ning, Wang Fei.

Exploring the effect of catgut implantation at acupoint on knee osteoarthritis based on the concept of "regulating bone with tendons" [J]. International Medicine and Health Guidance News, 2025, 31(11): 1900-1905.

参考文献

[1]Giorgino R, Albano D, Fusco S, et al. Knee osteoarthritis: epidemiology, pathogenesis, and mesenchymal stem cells: what else is new? An update[J]. Int J Mol Sci, 2023, 24(7):6405. DOI: 10.3390/ijms24076405.

[2]丁小姣,刘明,宁容容,等.透灸结合芪附麻辛桂姜汤治疗寒湿痹阻型膝骨关节炎[J].中医学报,2023,38(8):1765-1770. DOI:10.16368/j.issn.1674-8999.2023.08.286.

[3]龚秀英.基于中医传承辅助平台的中药熏洗治疗膝关节骨性关节炎的用药规律[J].国际医药卫生导报,2022,28(19):2671-2676. DOI:10.3760/cma.j.issn.1007-1245.2022. 19.002.

[4]黄振,张狄,宋双临,等.穴位埋线结合温针灸治疗膝骨关节炎的疗效研究[J].中华全科医学,2021,19(12):2115-2118. DOI:10.16766/j.cnki.issn.1674-4152.002250.

[5]张健,章新玲,江旭,等.基于"筋骨并重"理论刃针结合手法治疗膝骨性关节炎临床研究[J].针灸临床杂志,2023,39(7):19-24. DOI:10.19917/j.cnki.1005-0779.023130.

[6]Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis[J]. Ann Rheum Dis, 1957, 16(4):494-502. DOI: 10.1136/ard.16.4.494.

[7]中华医学会骨科分会关节外科学组,吴阶平医学基金会骨科学专家委员会.膝骨关节炎阶梯治疗专家共识(2018年版)[J/CD].中华关节外科杂志(电子版),2019,13(1):124-130. DOI:10.3877/cma.j.issn.1674- 134X. 2019.01.024.

[8]Faiz KW. VAS--visual analog scale[J]. Tidsskr Nor Laegeforen, 2014, 134(3):323. DOI: 10.4045/tidsskr.13.1145.

[9]Collins NJ, Misra D, Felson DT, et al. Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS) [J]. Arthritis Care Res (Hoboken), 2011, 63 Suppl 11(0 11):S208-S228. DOI: 10.1002/acr.20632.

[10]McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties[J]. Arthritis Rheum, 2001, 45(5):453-461. DOI: 10.1002/1529-0131(200110)45:5<453::aid-art365>3.0.co;2-w.

[11]周艳,王亚红,谭屏,等.元七骨痛酊联合塞来昔布治疗膝骨性关节炎的临床研究[J].现代药物与临床,2023,38(5):1187-1192. DOI:10.7501/j.issn.1674-5515.2023.05.027.

[12]王艳,贾晓慧,芦织,等.耳穴疗法治疗膝骨关节炎的疗效观察及对骨代谢和炎症因子的影响[J].上海针灸杂志,2024,43(11):1170-1176. DOI:10.13460/j.issn.1005-0957. 2024.11.0001.

[13]计颖颖,张礼娟,赵增趁.中药熏洗联合火龙灸治疗膝骨关节炎的临床研究[J].中国中医骨伤科杂志,2024,32(11):27-31. DOI:10.20085/j.cnki.issn1005-0205.241106.

[14]彭晓东,刘源,孙彦鹏,等.补肾活血方联合六步手法推拿治疗原发性膝骨关节炎的研究[J].中医研究,2024,37(9):30-33. DOI:10.3969/j.issn.1001-6910.2024.09.08.

[15]王军,韩莹.针刀"调筋治骨法"联合热敏灸治疗膝骨关节炎的临床研究[J].针灸临床杂志,2024,40(4):16-21. DOI:10.19917/j.cnki.1005-0779.024067.

[16]王佩光,张小文,麦美斯,等.广义估计方程评估浮针法联合穴位埋线治疗不同分期膝骨关节炎的疗效[J].中国组织工程研究,2025,29(8):1565-1571. DOI:10.12307/2025.345.

[17]林真静,曾红文,冯思玲.穴位埋线结合火针治疗膝骨关节炎的临床观察[J].广州中医药大学学报,2020,37(5):895-899. DOI:10.13359/j.cnki.gzxbtcm.2020.05.020.

[18]陈丽川,段波,喻昭,等.足三里和肾腧穴位埋线对大鼠类风湿关节炎NF-κB信号通路的影响[J].中国病理生理杂志,2022,38(7):1291-1296. DOI:10.3969/j.issn. 1000-4718.2022.07.017.

[19]Knapik M, Żelazo DA, Osowiecka K, et al. Efficacy of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials from the years 2000 to 2023[J]. J Clin Med, 2024, 13(10):2859. DOI: 10.3390/jcm13102859.

[20]Kumar S, Kumar H, Mittal A, et al. Correlation between synovial fluid levels of matrix metalloproteinase's (MMP-1, MMP-3, and MMP-9) and TNF-α with the severity of osteoarthritis knee in rural Indian population[J]. Indian J Orthop, 2023, 57(10):1659-1666. DOI: 10.1007/s43465-023-00974-8.

[21]Arora V, Sharma M, Bishnoi S, et al. Clinical and biochemical correlation of intra-articular platelet-rich plasma and corticosteroid using serum matrix metalloproteinase 3 (MMP-3) levels in osteoarthritis of knee[J]. Cureus, 2023, 15(5):e39625. DOI: 10.7759/cureus.39625.

[22]张强,周飞,常睿,等.加巴喷丁联合透明质酸钠对膝关节骨性关节炎患者疼痛和血清β-内啡肽、前列腺素E2水平的影响[J].医学临床研究,2022,39(4):503-506. DOI:10.3969/j.issn.1671-7171.2022.04.007.